Alexza Pharma beats by $0.33, misses on revenue

|About: Alexza Pharmaceuticals,... (ALXA)|By:, SA News Editor

Alexza Pharma (NASDAQ:ALXA): Q2 EPS of -$0.34 beats by $0.33.

Revenue of $1.48M (-96.6% Y/Y) misses by $0.76M.

Shares -2%.